- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04228107
Treatment Phenotypes for Adolescents With Asthma
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- Childrens Hospital Colorado
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
For adolescent participants:
Inclusion Criteria:
- Diagnosis of asthma On an inhaled controller and rescue medication for which a propeller health device is available
Exclusion Criteria:
Other significant chronic lung disease (from problem list)
- Cystic fibrosis
- Chronic respiratory failure
- Tracheostomy status
- Intersititial lung disease
- Significant developmental delay
- Taking more than 3 asthma related medications
- Primary language other than English, Spanish, Catalan, Dutch, French, German or Italian
Healthcare providers will be recruited as well to participate in focus groups as part of specific aim 2.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Cohort
Participants will be enrolled in medication use monitoring. Their medication use patterns will be available to themselves and their guardians via a smartphone application, and to their asthma care providers via a portal. There will be no interventions to change medication use patterns. A portion of them will be asked to participate in a semistructured interview during which they will be asked questions about their perception of their asthma, health beliefs regarding medication use, and what they feel would be the most helpful to get them to take their asthma medicines. Additionally a small group of healthcare providers will be asked to participate in a focus group to collect qualitative data on medication use barriers and facilitators |
This is an observational study of medication use patterns.
The propeller health device has reminders for controller medication use and gives feedback regarding medication use to the participant, their guardian and their asthma provider
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Treatment Phenotypes
Time Frame: 12 months
|
The Investigators will calculate the number of participants that fall into the following treatment phenotypes: "Well controlled-good adherence", "Well controlled-poor adherence", "Poorly controlled-good adherence", "Poorly controlled-poor adherence".
The investigators will use group based trajectory modeling to evaluate adherence and control phenotypes; In essence, they will evaluate the adherence trajectory of each subject, as well as the control phenotype of each patient, and then use this information to determine into which of the four groups the participant falls.
The outcome reported will be the number of subjects in each group.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Qualitative information regarding barriers for medication use
Time Frame: 12 months
|
Qualitative data (semistructured interviews with patients regarding barriers to medication use.
|
12 months
|
Qualitative information regarding barriers for medication use
Time Frame: 12 months
|
Qualitative data (focus groups with providers) regarding barriers to medication use.
|
12 months
|
Qualitative information regarding facilitators for medication use
Time Frame: 12 months
|
Qualitative data (semistructured interviews with patients) to determine facilitators to medication use.
|
12 months
|
Qualitative information regarding facilitators for medication use
Time Frame: 12 months
|
Qualitative data (focus groups with healthcare providers) to determine facilitators to medication use.
|
12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Heather EH De Keyser, MD MS, University of Colorado, Denver
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-1861
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Asthma in Children
-
Istituto di Farmacologia Traslazionale - sede di...Not yet recruitingAsthma in Children | Children, Only | Serious Game
-
University of FloridaNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingAsthma in ChildrenUnited States
-
ResMedCompletedAsthma in ChildrenUnited States
-
University of WashingtonNational Institute of Environmental Health Sciences (NIEHS); National Institute... and other collaboratorsCompleted
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Duke UniversityRecruitingAsthma in ChildrenUnited States
-
Rambam Health Care CampusCompleted
-
Shaoxing Maternity and Child Health Care HospitalRecruiting
-
University of LiverpoolNot yet recruiting
Clinical Trials on Medication monitoring
-
University of TennesseeKali Care; Barney's Pharmacy; Creative Care Pharmacy; Hutton Pharmacy; Mustang DrugTerminated
-
Mbarara University of Science and TechnologyRecruiting
-
University of PittsburghRANDCompletedAdverse Drug EventsUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Hypertension
-
Massachusetts General HospitalNational Cancer Institute (NCI)CompletedBreast Cancer | Adherence, MedicationUnited States
-
Shalvata Mental Health CenterSHL Telemedicine Ltd.UnknownSchizophrenia | Schizoaffective DisorderIsrael
-
University of Colorado, DenverCompleted
-
National Cancer Institute (NCI)CompletedNeurofibromatosis 1 | Neurofibroma, PlexiformUnited States
-
University of SharjahNot yet recruitingHypertension | Obesity | Pharmacist-Patient Relations | Diabete Type 2
-
VA Office of Research and DevelopmentCompletedCardiovascular Diseases | Diabetes MellitusUnited States